Baudax Bio Ownership | Who Owns Baudax Bio?
Baudax Bio Ownership Summary
Baudax Bio is owned by 0.01% institutional investors, and 99.99% retail investors. iShares Core S&P Total US Stock Mkt ETF is the top mutual fund, with 0% of its assets in Baudax Bio shares.
BXRX Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Baudax Bio | 0.01% | - | 99.99% |
Sector | Healthcare Stocks | 47.06% | 8.01% | 44.93% |
Industry | Biotech Stocks | 44.97% | 7.82% | 47.21% |
Institutional Shareholders
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2022 | 1 | -93.33% | 71 | -100.00% | - | 0.04% | - | -100.00% | 1 | -66.67% |
Sep 30, 2022 | 15 | - | 1,432,997 | 12.24% | 4 | 26.37% | 10 | 25.00% | 3 | - |
Jun 30, 2022 | 15 | -6.25% | 1,276,758 | 2.68% | 4 | 24.78% | 8 | -50.00% | 3 | - |
Mar 31, 2022 | 16 | - | 1,243,391 | - | 4 | - | 16 | - | - | - |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
iShares Core S&P Total US Stock Mkt ETF | 2.00 | - | 2.00 |
NT Quality Small Cap Core | 1.00 | - | - |
NT Quality SCC US Fund - L | 1.00 | - | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Dec 15, 2022 | HENWOOD GERALDINE | President and CEO | Buy | $3.06K |
Sep 22, 2021 | HENWOOD GERALDINE | President and CEO | Buy | $4.80K |
Aug 31, 2021 | CHURCHILL WINSTON J | - | Buy | $62.93K |
Aug 20, 2021 | Casten Richard S | Chief Financial Officer | Buy | $25.50K |
Jun 07, 2021 | CHURCHILL WINSTON J | - | Buy | $7.85K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2023 Q4 | - | - |
2023 Q3 | - | - |
2022 Q4 | 1 | - |
2022 Q2 | - | - |
2021 Q4 | - | - |
BXRX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools